Red blood cells (RBCs) constitute a unique drug delivery system as a biologic or hybrid
carrier capable of greatly enhancing pharmacokinetics, altering pharmacodynamics (for …

The facilitated diffusion of glucose, galactose, fructose, urate, myoinositol, and
dehydroascorbic acid in mammals is catalyzed by a family of 14 monosaccharide transport …

Glucose-responsive insulin delivery systems that mimic insulin secretion activity in the
pancreas show great potential to improve clinical therapeutic outcomes for people with type …

The metabolic state of quiescent hematopoietic stem cells (HSCs) is an important regulator
of self-renewal, but it is unclear whether or how metabolic parameters contribute to HSC …

Glucose‐responsive delivery of insulin mimicking the function of pancreatic β‐cells to
achieve meticulous control of blood glucose (BG) would revolutionize diabetes care. Here …

Research progress to understand the role of vitamin C (ascorbic acid) in human health has
been slow in coming. This is predominantly the result of several flawed approaches to study …

Strategies to prevent diabetic microvascular angiopathy focus on the vascular endothelium.
Because red blood cells (RBCs) are less deformable in diabetes, we explored an original …

Neonatal anemia is a frequent occurrence in neonatal intensive care units. Red blood cell
transfusion criteria in case of blood loss are clearly defined but optimal hemoglobin or …

Metabolic regulation of hematopoietic stem cell commitment a... : Current Opinion in
Hematology Metabolic regulation of hematopoietic stem cell commitment and erythroid …

The metabolic changes controlling the stepwise differentiation of hematopoietic stem and
progenitor cells (HSPCs) to mature erythrocytes are poorly understood. Here, we show that …